Ayurnepal.com

Nepali Language (Nepal)English (United Kingdom)

New Research in Bronchial Asthma

 

Management of Bronchial Asthma with Herbo Mineral Ayurvedic Drugs


Bronchial asthma is chronic debilitating disease of varied etiology. Various causative factors such as allergies due to dust, fumes and pollen grains along with genetic factors have been studied and investigated. The growing environmental pollution with rapid and extensive industrialization is also responsible for aggravation of this disease. The alarming rise in the incidence of this disease in metropolitan cities has posed a serious problem. Keeping these factors in view and also to find a simple and easily accessible treatment, the following studies were carried out.

Clinical studies

Study-I:

The two combinations of Naradiya Lakshmi Vilasa Rasa with Godanti Bhasma and Swasa Kesari (Kantakari with Godanti Bhasma) have been evolved and put on trial in separate groups of patients.

Dose

Group A:

This group constituted Naradiya Laksmi Vilasa Rasa and Godanti Bhasma in a dose of 500 mg. and 1 gm. respectively thrice a day.

Group B:

This group constituted Shwasa Kesari tablets (each tabletsof 500 mg.) three tablets thrice a day.

The efficacy of the treatment has been evaluated on the basis of clinical improvement i.e. changes in signs and symptoms of the disease. In addition, a quantitative assessment of primary functions tests such as vital capacity, peak flow rate, breath holding time etc. have also been undertaken. The data have been statistically analysed.

Results

Out of 783 patients studied with Shwasa Kesari, most of the patients showed good response. Only less then 5% showed poor effect on the disease. Laksmi Vilasa Rasa, Godanti combination was equally effective and about 8% did not show any affect of the therapy.

It may be concluded that:

Both groups of drugs for the treatment of Tamaka shwasa are quite effective.

The action of these groups of drugs, when given in the doses prescribed is marked; lesser doses may not show good results.

 

Both groups of drugs are safe and no toxic and side effects were noted during the study except that of feeling of thirst in 3% of the cases in Group B.

Beside the treatment, the patients of Tamaka Shwasa must follow the regimen of ‘Pathya’ and ‘Apathya’ (Do’s & Don’t’s).

Study-II:

Kantakari whole plant was studied on 151 patients. The drug was administered in the form of Kwatha (Decoction) in the dose of 30 ml. three times a day. The effect of the drug was evident in the most of the patients (59.09%) who completed the full course of 4 weeks.

Study-III:

Sirisa (Albizzia lebbeck Benth.) tvak (Stem bark) administered in the form of decoction was studied on 391 patients. A six-week course of the drug, 30 ml. three times a day has shown reasonably good response. 50% of the patients who completed the full course of treatment have shown definite relief.

 

Source:http://ccras.nic.in

 

Ayurveda Blog